To find out whether lung cancer cells could also be a source of FKN in lung cancer patients, we quantified in vitro FKN secretion by a collection of 10 human lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC) cell lines. This evidence concerns the gene CX3CL1 and lung carcinoma.